ISPECIMEN INC (ISPC)       1.68  -0.07 (-4%)

1.68  -0.07 (-4%)

US45032V1089 - Common Stock

ISPECIMEN INC1.68

NASDAQ:ISPC (2/3/2023, 7:00:03 PM)-0.07 (-4%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Technology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-08 2022-11-08/bmo Earnings (Next) N/A N/A
Ins Owners 8.78% Inst Owners 5.3%
Market Cap 14.98M Shares 8.92M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.22
IPO 06-17 2021-06-17

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ISPC Daily chart

Company Profile

iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.

Company Info

ISPECIMEN INC

450 Bedford St Ste 1010

Lexington MASSACHUSETTS

P: 17813016700.0

CEO: Christopher Ianelli

Employees: 59

Website: http://www.ispecimen.com/

ISPC News

News Image11 days ago - iSpecimen InciSpecimen Appoints Eric Langlois as Chief Revenue Officer

Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s Former SVP of Sales and Business Development...

News Image12 days ago - iSpecimen InciSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that...

News Image16 days ago - iSpecimen InciSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on January 25, 2023

LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that...

News Image24 days ago - iSpecimen InciSpecimen Names Tracy Curley as Chief Executive Officer

Previously Appointed Interim CEO in September 2022...

News Image2 months ago - iSpecimen InciSpecimen Appoints Joseph J. Basile to Board of Directors

Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimen...

News Image3 months ago - iSpecimen InciSpecimen Reports Third Quarter 2022 Financial and Operating Results

- Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -...

ISPC Twits

Here you can normally see the latest stock twits on ISPC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example